These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 10639966

  • 1. Blood transfusion.
    Nerlich S.
    Aust Nurs J; 1998 Jun; 5(11):suppl i-iv. PubMed ID: 10639966
    [Abstract] [Full Text] [Related]

  • 2. [Heparinized venous approaches].
    Arnáiz Betolaza L, Novoa Vences E.
    Rev Enferm; 1996 May; 19(213):64-5. PubMed ID: 8716873
    [No Abstract] [Full Text] [Related]

  • 3. Current trends in blood component therapy: the evolution of a safer, more effective product.
    Baranowski L.
    J Intraven Nurs; 1992 May; 15(3):136-51. PubMed ID: 1608013
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Administration of blood products.
    McMahon M.
    Int J Trauma Nurs; 2000 May; 6(3):95-100. PubMed ID: 10891848
    [No Abstract] [Full Text] [Related]

  • 6. Bibliography. Current world literature. Transfusion medicine.
    Curr Opin Hematol; 2001 Nov; 8(6):B140-51. PubMed ID: 11710320
    [No Abstract] [Full Text] [Related]

  • 7. Blood component replacement therapy.
    Coffland FI, Sheleton DM.
    Crit Care Nurs Clin North Am; 1993 Sep; 5(3):543-56. PubMed ID: 8217049
    [Abstract] [Full Text] [Related]

  • 8. [Blood products].
    Montloin A.
    Rev Infirm; 1992 Mar; 42(6):33-41. PubMed ID: 1598492
    [No Abstract] [Full Text] [Related]

  • 9. Blood-component therapy: selection, administration and monitoring.
    Chiaramonte D.
    Clin Tech Small Anim Pract; 2004 May; 19(2):63-7. PubMed ID: 15179925
    [Abstract] [Full Text] [Related]

  • 10. Research opportunities for pathogen reduction/inactivation of blood components: summary of an NHLBI workshop.
    Klein HG, Glynn SA, Ness PM, Blajchman MA, NHLBI Working Group on Research Opportunities for the Pathogen Reduction/Inactivation of Blood Components.
    Transfusion; 2009 Jun; 49(6):1262-8. PubMed ID: 19392769
    [Abstract] [Full Text] [Related]

  • 11. [Blood transfusion and monitoring. Blood products for transfusion. Indications].
    Gaspard M.
    Soins; 1996 Apr; (605):18-9. PubMed ID: 8716243
    [No Abstract] [Full Text] [Related]

  • 12. [Substitutive hemotransfusion in newborns with surgical pathologies].
    Strogonov IA, Dubynina NF, Gorovaia TP, Mel'nikova NI, Doletskiĭ AS.
    Anesteziol Reanimatol; 2003 Apr; (1):20-4. PubMed ID: 12696448
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Platelets, frozen plasma, and cryoprecipitate: what is the clinical evidence for their use in the neonatal intensive care unit?
    Poterjoy BS, Josephson CD.
    Semin Perinatol; 2009 Feb; 33(1):66-74. PubMed ID: 19167583
    [Abstract] [Full Text] [Related]

  • 17. Blood component therapy and changing transfusion triggers.
    Williford PD, Bensky KP.
    CRNA; 1994 Nov; 5(4):139-50. PubMed ID: 7881351
    [Abstract] [Full Text] [Related]

  • 18. [Indications for labile blood products].
    Jeanne M, Rasonglès P.
    Rev Prat; 2001 Jun 30; 51(12):1318-27. PubMed ID: 11503505
    [Abstract] [Full Text] [Related]

  • 19. When, why and how to order blood?
    Steenssens L.
    Acta Anaesthesiol Belg; 2003 Jun 30; 54(4):313-4. PubMed ID: 14719351
    [No Abstract] [Full Text] [Related]

  • 20. [Transfusion of blood and products derived from blood].
    Wautier JL.
    Rev Prat; 1999 Feb 15; 49(4):409-13. PubMed ID: 10319693
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.